Patents by Inventor Richard L. Schaub

Richard L. Schaub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PD-1/LAG-3 BISPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20240101718
    Abstract: The present disclosure describes a bispecific antibody targeting PD-1 and LAG-3 for use in the treatment of advanced malignancies such as melanoma and squamous cell carcinoma of the head and neck.
    Type: Application
    Filed: September 27, 2023
    Publication date: March 28, 2024
    Inventors: Richard L. Schaub, Patrick Mayes
  • JAK1 pathway inhibitors for the treatment of chronic lung allograft dysfunction
    Patent number: 11896595
    Abstract: This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: February 13, 2024
    Assignee: Incyte Corporation
    Inventors: Richard L. Schaub, Kevin O'Hayer
  • JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Publication number: 20220331325
    Abstract: This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
    Type: Application
    Filed: June 30, 2022
    Publication date: October 20, 2022
    Inventors: Richard L. Schaub, Kevin O`Hayer
  • JAK1 pathway inhibitors for the treatment of chronic lung allograft dysfunction
    Patent number: 11406640
    Abstract: This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: August 9, 2022
    Assignee: Incyte Corporation
    Inventors: Richard L. Schaub, Kevin O'Hayer
  • JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Publication number: 20200281931
    Abstract: This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating chronic lung allograft dysfunction such as, e.g., bronchiolitis obliterans syndrome.
    Type: Application
    Filed: March 5, 2020
    Publication date: September 10, 2020
    Inventors: Richard L. Schaub, Kevin O`Hayer